Provectus Biopharmaceuticals, Inc. (PVCT) SEC Filings — 2025
10 SEC filings for Provectus Biopharmaceuticals, Inc. (PVCT) in 2025.
Filings
- Provectus Biopharma's Losses Widen Amid Plummeting Cash Reserves — 10-Q · Nov 13, 2025
- Provectus Biopharma Files Q2 2025 10-Q — 10-Q · Aug 14, 2025
- Provectus Biopharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 20, 2025
- Provectus Biopharmaceuticals Files 8-K — 8-K · Jun 18, 2025
- Provectus Biopharma Files 2024 Annual Report Amendment — 10-K/A · May 16, 2025
- Provectus Biopharma Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Provectus Biopharma Proxy: Executive Pay & Equity Awards Detailed — DEF 14A · May 1, 2025
- Provectus Biopharmaceuticals Changes Auditors — 8-K · Apr 16, 2025
- Provectus Biopharma Files 2024 10-K — 10-K · Mar 28, 2025
- Provectus Biopharma Reports Material Agreement and Equity Sales — 8-K · Jan 22, 2025